These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26363110)

  • 1. Delivery of tissue plasminogen activator and streptokinase magnetic nanoparticles to target vascular diseases.
    Tadayon A; Jamshidi R; Esmaeili A
    Int J Pharm; 2015 Nov; 495(1):428-438. PubMed ID: 26363110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted thrombolysis of tissue plasminogen activator and streptokinase with extracellular biosynthesis nanoparticles using optimized Streptococcus equi supernatant.
    Tadayon A; Jamshidi R; Esmaeili A
    Int J Pharm; 2016 Mar; 501(1-2):300-10. PubMed ID: 26873394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle.
    Chen JP; Yang PC; Ma YH; Tu SJ; Lu YJ
    Int J Nanomedicine; 2012; 7():5137-49. PubMed ID: 23055726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis.
    Marsh JN; Senpan A; Hu G; Scott MJ; Gaffney PJ; Wickline SA; Lanza GM
    Nanomedicine (Lond); 2007 Aug; 2(4):533-43. PubMed ID: 17716136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.
    Chen HA; Ma YH; Hsu TY; Chen JP
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy.
    Huang Y; Yu L; Ren J; Gu B; Longstaff C; Hughes AD; Thom SA; Xu XY; Chen R
    J Control Release; 2019 Apr; 300():1-12. PubMed ID: 30807804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in clot lysis among patients demonstrated in vitro with three thrombolytic agents (tissue-type plasminogen activator, streptokinase and urokinase).
    Musselman DR; Tate DA; Oberhardt BJ; Abruzzini AF; Blauwet MB; Koch G; Dehmer GJ
    Am J Cardiol; 1994 Mar; 73(8):544-9. PubMed ID: 8147298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy.
    Absar S; Nahar K; Kwon YM; Ahsan F
    Pharm Res; 2013 Jun; 30(6):1663-76. PubMed ID: 23468049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution.
    Heid S; Unterweger H; Tietze R; Friedrich RP; Weigel B; Cicha I; Eberbeck D; Boccaccini AR; Alexiou C; Lyer S
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolysis using liposomal-encapsulated streptokinase: an in vitro study.
    Nguyen PD; O'Rear EA; Johnson AE; Lu R; Fung BM
    Proc Soc Exp Biol Med; 1989 Dec; 192(3):261-9. PubMed ID: 2602391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A randomized study of streptokinase and recombinant tissue plasminogen activator, with and without heparin, in patients with acute myocardial infarction. The results of GISSI-2/International tPA/SK Mortality Trial].
    Steffensen R; Sandøe E
    Ugeskr Laeger; 1991 Oct; 153(41):2880-3. PubMed ID: 1949301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
    Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
    Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombolysis in acute myocardial infarction. Streptokinase or r-TPA?].
    Silva LA; Ribeiro E; Carneiro RC; Kaissar S; Reis Filho A; Torossian SP; Tavares JR; Buffolo E; Amino JG; Duprat Filho R
    Arq Bras Cardiol; 1990 Jul; 55(1):13-7. PubMed ID: 2127353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro Model System for Evaluating Remote Magnetic Nanoparticle Movement and Fibrinolysis.
    Pernal SP; Willis AJ; Sabo ME; Moore LM; Olson ST; Morris SC; Creighton FM; Engelhard HH
    Int J Nanomedicine; 2020; 15():1549-1568. PubMed ID: 32210551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
    Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
    Mühl D; Füredi R; Gecse K; Ghosh S; Falusi B; Bogár L; Roth E; Lantos J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):661-7. PubMed ID: 17890954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted thrombolysis by using of magnetic mesoporous silica nanoparticles.
    Wang M; Zhang J; Yuan Z; Yang W; Wu Q; Gu H
    J Biomed Nanotechnol; 2012 Aug; 8(4):624-32. PubMed ID: 22852472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trastuzumab-conjugated liposome-coated fluorescent magnetic nanoparticles to target breast cancer.
    Jang M; Yoon YI; Kwon YS; Yoon TJ; Lee HJ; Hwang SI; Yun BL; Kim SM
    Korean J Radiol; 2014; 15(4):411-22. PubMed ID: 25053899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of PEG-containing liposomal formulations on in vivo pharmacokinetics of streptokinase.
    Jin SE; Kim IS; Kim CK
    Arch Pharm Res; 2015 Oct; 38(10):1822-9. PubMed ID: 25851624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.